Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| Revenues | 461.1 | 232.9 | 115.7 |
| Revenue growth | 97.9% | 101.4% | |
| Cost of goods sold | 211.1 | 142.7 | 115.1 |
| Gross profit | 250.0 | 90.2 | 0.6 |
| Gross margin | 54.2% | 38.7% | 0.5% |
| Sales and marketing | 51.2 | 23.5 | 12.8 |
| Research and development | 28.9 | 19.1 | 17.6 |
| General and administrative | 132.4 | 106.1 | 77.0 |
| EBIT | -282.6 | -259.9 | -243.8 |
| EBIT margin | -61.3% | -111.6% | -210.8% |
| Pre-tax income | -165.2 | -294.1 | -250.0 |
| Income taxes | 0.5 | 0.2 | 0.3 |
| Net income | -165.7 | -294.4 | -250.3 |
| Net margin | -35.9% | -126.4% | -216.4% |
| |
| Diluted EPS | ($0.80) | ($25.02) | ($27.22) |
| Shares outstanding (diluted) | 206.0 | 11.8 | 9.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|